Lacierda, Tiffany Shamz G.

HRN: 28-51-52  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/02/2026
02/08/2026
IV
500mg
Q8
Pneumoperitoneum Secondary To Ruptured Viscus Secondary To Blunt Abdominal Trauma
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines